These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17624128)

  • 41. [Over-the-counter drugs, subsidy and safety].
    Kampmann JP
    Ugeskr Laeger; 1991 May; 153(20):1401-2. PubMed ID: 1674178
    [No Abstract]   [Full Text] [Related]  

  • 42. [The latest tendency of uncontrolled substance inquiries to JPIC].
    Kuroki Y
    Chudoku Kenkyu; 2004 Jul; 17(3):241-3. PubMed ID: 15495682
    [No Abstract]   [Full Text] [Related]  

  • 43. The epidemiology of poisonings in infants <6 months of age.
    Kuspis DA; Mrvos R; Krenzelok EP
    Przegl Lek; 2007; 64(4-5):197-8. PubMed ID: 17724865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overdose reports--an underutilized resource.
    Anderson BD
    Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):447-8. PubMed ID: 14513657
    [No Abstract]   [Full Text] [Related]  

  • 45. Twenty five years of poison center experience with propoxyphene overdoses the FDA could not find.
    Hayes BD; Anderson BD
    Clin Toxicol (Phila); 2009 Nov; 47(9):905-6. PubMed ID: 19814605
    [No Abstract]   [Full Text] [Related]  

  • 46. Omeprazole-induced dermatomyositis.
    Pan Y; Chong AH; Williams RA; Green J; Sinclair R
    Br J Dermatol; 2006 Mar; 154(3):557-8. PubMed ID: 16445794
    [No Abstract]   [Full Text] [Related]  

  • 47. Poison centers detect an unexpectedly frequent number of adverse drug reactions to lisdexamfetamine.
    Spiller HA; Griffith JR; Anderson DL; Weber JA; Aleguas A
    Ann Pharmacother; 2008 Jul; 42(7):1142-3. PubMed ID: 18594051
    [No Abstract]   [Full Text] [Related]  

  • 48. [Teenage suiside attempts using OTC drugs].
    Araki H
    Chudoku Kenkyu; 2012 Mar; 25(1):77-80. PubMed ID: 22568351
    [No Abstract]   [Full Text] [Related]  

  • 49. The state of dietary supplement adverse event reporting in the United States.
    Gardiner P; Sarma DN; Low Dog T; Barrett ML; Chavez ML; Ko R; Mahady GB; Marles RJ; Pellicore LS; Giancaspro GI
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):962-70. PubMed ID: 18613260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Over-the-counter-drugs: epidemiology, adverse reactions, overdose deaths, and mass media promotion.
    Inciardi JA
    Addict Dis; 1977; 3(2):253-72. PubMed ID: 28642
    [No Abstract]   [Full Text] [Related]  

  • 51. Autoimmune haemolytic anaemia due to Omeprazole.
    Butt MI; Sajid S; Sobolewski S
    Ir Med J; 2007 Feb; 100(2):372. PubMed ID: 17432815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cimetidine and hot flashes.
    Shuster J
    Nursing; 2000 Feb; 30(2):68. PubMed ID: 11000844
    [No Abstract]   [Full Text] [Related]  

  • 53. Do OTC 'ulcer drugs' pose problems when used with dental medications?
    Biron CR
    RDH; 1995 Dec; 15(12):25, 39. PubMed ID: 9534484
    [No Abstract]   [Full Text] [Related]  

  • 54. Decoding "drug imprints" at the millennium: a proposal to increase accuracy and reduce costs.
    Marder S; Winkler T; Tadaki K; Bobbink S; Robertson WO
    Vet Hum Toxicol; 2001 Feb; 43(1):46-7. PubMed ID: 11205080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Folic acid calls to poison centers in Texas, 1998-2003.
    Forrester MB
    Hum Exp Toxicol; 2005 Aug; 24(8):423-7. PubMed ID: 16138734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Occupational airborne contact dermatitis from omeprazole.
    Conde-Salazar L; Blancas-Espinosa R; Pérez-Hortet C
    Contact Dermatitis; 2007 Jan; 56(1):44-6. PubMed ID: 17177711
    [No Abstract]   [Full Text] [Related]  

  • 57. [Inappropriate use of over-the-counter (OTC) drugs and their administration].
    Moriya F
    Chudoku Kenkyu; 2012 Jun; 25(2):97-8. PubMed ID: 22774583
    [No Abstract]   [Full Text] [Related]  

  • 58. Cutaneous hyperpigmentation induced by omeprazole mimicking ashy dermatosis.
    Ramírez-Hernández M; Martínez-Escribano JA; Martínez-Barba E; Alcolea-Rubio LA; Ibarra-Berrocal IJ
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):584-7. PubMed ID: 16684288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Omeprazole (correction of omepraxole) and ocular damage. Concerns on safety of drug are unwarranted.
    Lessell S
    BMJ; 1998 Jan; 316(7124):67; author reply 68. PubMed ID: 9451276
    [No Abstract]   [Full Text] [Related]  

  • 60. Rhabdomyolysis associated with omeprazole.
    Nozaki M; Suzuki T; Hirano M
    J Gastroenterol; 2004 Jan; 39(1):86. PubMed ID: 14767743
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.